Showing results (41-50 of 88) with videos related to
Sort By:
Pageof 9
The Journal of Urology|May 1, 1997
Neoadjuvant androgen withdrawal therapy decreases local recurrence rates following tumor excision in the Shionogi tumor modelM E Gleave, N Sato, S L Goldenberg, et al.British Journal of Urology|February 1, 1997
Early experience with high-intensity focused ultrasound for the treatment of benign prostatic hypertrophyL D Sullivan, M G McLoughlin, L G Goldenberg, et al.Cancer Research|April 15, 1997
A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID miceN Sato, M E Gleave, N Bruchovsky, et al.Cancer|November 1, 1982
A critical evaluation of a specific radioimmunoassay for prostatic acid phosphataseS L Goldenberg, H K Silver, L D Sullivan, et al.British Journal of Urology|June 20, 1998
An evaluation of quality of life in patients with continent urinary diversions after cystectomyL D Sullivan, V D Chow, D S Ko, et al.Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 1, 1996
[Hormone release and intermittent hormonal therapy in the LN CaP model of human prostate cancer]M Gleave, N Santo, P S Rennie, et al.Journal of Neurochemistry|August 1, 1986
Activation of glutamate apodecarboxylase by succinic semialdehyde and pyridoxamine 5'-phosphateT G Porter, S B Martin, D L MartinNeurochemistry International|July 14, 1999
Regional distribution and relative amounts of glutamate decarboxylase isoforms in rat and mouse brainS N Sheikh, S B Martin, D L MartinJournal of Neurochemistry|August 1, 1990
Glutamate-dependent active-site labeling of brain glutamate decarboxylaseD L Martin, S J Wu, S B MartinCancer|May 1, 1993
Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigenK Akakura, N Bruchovsky, S L Goldenberg, et al.Pageof 9